Citrullination as a novel posttranslational modification of matrix metalloproteinases.


Journal

Matrix biology : journal of the International Society for Matrix Biology
ISSN: 1569-1802
Titre abrégé: Matrix Biol
Pays: Netherlands
ID NLM: 9432592

Informations de publication

Date de publication:
01 2021
Historique:
received: 02 07 2020
revised: 30 10 2020
accepted: 30 10 2020
pubmed: 7 11 2020
medline: 29 10 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Matrix metalloproteinases (MMPs) are enzymes with critical roles in biology and pathology. Glycosylation, nitrosylation and proteolysis are known posttranslational modifications (PTMs) regulating intrinsically the activities of MMPs. We discovered MMP citrullination by peptidyl arginine deiminases (PADs) as a new PTM. Upon hypercitrullination, MMP-9 acquired a higher affinity for gelatin than control MMP-9. Furthermore, hypercitrullinated proMMP-9 was more efficiently activated by MMP-3 compared to control MMP-9. JNJ0966, a specific therapeutic inhibitor of MMP-9 activation, inhibited the activation of hypercitrullinated proMMP-9 by MMP-3 significantly less in comparison with control proMMP-9. The presence of citrullinated/homocitrullinated MMP-9 was detected in vivo in neutrophil-rich sputum samples of cystic fibrosis patients. In addition to citrullination of MMP-9, we report efficient citrullination of MMP-1 and lower citrullination levels of MMP-3 and MMP-13 by PAD2 in vitro. In conclusion, citrullination of MMPs is a new PTM worthy of additional biochemical and biological studies.

Identifiants

pubmed: 33157227
pii: S0945-053X(20)30095-0
doi: 10.1016/j.matbio.2020.10.005
pii:
doi:

Substances chimiques

Hydrolases EC 3.-
Matrix Metalloproteinase 13 EC 3.4.24.-
Matrix Metalloproteinases EC 3.4.24.-
Matrix Metalloproteinase 3 EC 3.4.24.17
Matrix Metalloproteinase 9 EC 3.4.24.35
PADI2 protein, human EC 3.5.3.15
Protein-Arginine Deiminase Type 2 EC 3.5.3.15
arginine deiminase EC 3.5.3.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-83

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there is no conflict of interest regarding the publication of this article.

Auteurs

Lise Boon (L)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium.

Estefania Ugarte-Berzal (E)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium.

Erik Martens (E)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium.

Pierre Fiten (P)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium.

Jennifer Vandooren (J)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium.

Rik Janssens (R)

Rega Institute for Medical Research, Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven 3000, Belgium.

Marfa Blanter (M)

Rega Institute for Medical Research, Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven 3000, Belgium.

Karen Yu (K)

Rega Institute for Medical Research, Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven 3000, Belgium.

Mieke Boon (M)

University Hospitals Leuven, Department of Pediatrics and Department of Development and Regeneration, KU Leuven, Leuven 3000, Belgium.

Sofie Struyf (S)

Rega Institute for Medical Research, Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven 3000, Belgium.

Paul Proost (P)

Rega Institute for Medical Research, Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven 3000, Belgium.

Ghislain Opdenakker (G)

Rega Institute for Medical Research, Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 box 1044, Leuven 3000, Belgium. Electronic address: ghislain.opdenakker@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH